VCEL
#1865
Vericel Corporation - Common Stock
47.4 9 USD
+0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.04%
Changement Mensuel
+25.40%
Evolution sur 6 mois
+26.98%
Changement Annuel
+30.65%
Clôture Précédente
47.0 0
Open
47.4 9
Low
47.4 9
High
47.4 9
Volume
113
Financials
- Market Capitalization 2.43 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
112.53
ratio cours/chiffre d'affaires
6.8
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1836 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 59.31 USD | +2.01% | -13.26% | -4.46% | -10.22% | 2.55 B USD | ||
| 1845 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.91 USD | -5.17% | -4.16% | +13.13% | +10.11% | 2.52 B USD | ||
| 1872 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 40.55 USD | -1.65% | +2.35% | +36.58% | -6.55% | 2.41 B USD | ||
| 1885 |  NRIX Nurix Therapeutics, Inc. - Common stock | 22.71 USD | -1.52% | -5.65% | +32.81% | +102.59% | 2.36 B USD |